» Articles » PMID: 35530973

Nanomedicine: An Emerging Novel Therapeutic Strategy for Hemorrhagic Stroke

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2022 May 9
PMID 35530973
Authors
Affiliations
Soon will be listed here.
Abstract

Hemorrhagic stroke is one of the most devastating diseases worldwide due to a high rate of disability and mortality with few effective treatments. Recent advances in nanomedicines to promote hemostasis, drug delivery, neuroprotection, and nerve regeneration may provide insight into hemorrhagic stroke treatment. In this review, we first view the pathophysiology and conventional therapeutics of hemorrhagic stroke. Second, we comprehensively summarize the current nanomedicines applied in hemorrhagic stroke, including inorganic nanomaterials, polymer-based nanomaterials, lipid-based nanomaterials, self-assembling peptide-based hydrogel, exosomes, and gel systems. Finally, the challenges, opportunities, and future perspectives of nanomedicines for hemorrhagic stroke are discussed. Thus, this review promotes greater exploration of effective therapies for hemorrhagic stroke with nanomedicines.

Citing Articles

Application and Development of Cell Membrane Functionalized Biomimetic Nanoparticles in the Treatment of Acute Ischemic Stroke.

Li Y, Wu C, Yang R, Tang J, Li Z, Yi X Int J Mol Sci. 2024; 25(15).

PMID: 39126107 PMC: 11313357. DOI: 10.3390/ijms25158539.


Hydrogel-Based Therapies for Ischemic and Hemorrhagic Stroke: A Comprehensive Review.

Rotaru-Zavaleanu A, Dinescu V, Aldea M, Gresita A Gels. 2024; 10(7).

PMID: 39057499 PMC: 11276304. DOI: 10.3390/gels10070476.


Neuroinflammation: A Critical Factor in Neurodegenerative Disorders.

Suleiman Khoury Z, Sohail F, Wang J, Mendoza M, Raake M, Tahoor Silat M Cureus. 2024; 16(6):e62310.

PMID: 39006715 PMC: 11246070. DOI: 10.7759/cureus.62310.


The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets.

Adamu A, Li S, Gao F, Xue G Front Aging Neurosci. 2024; 16:1347987.

PMID: 38681666 PMC: 11045904. DOI: 10.3389/fnagi.2024.1347987.


Advanced Nano-Drug Delivery Systems in the Treatment of Ischemic Stroke.

Zhang J, Chen Z, Chen Q Molecules. 2024; 29(8).

PMID: 38675668 PMC: 11054753. DOI: 10.3390/molecules29081848.


References
1.
Li Z, Liang G, Ma T, Li J, Wang P, Liu L . Blood-brain barrier permeability change and regulation mechanism after subarachnoid hemorrhage. Metab Brain Dis. 2014; 30(2):597-603. DOI: 10.1007/s11011-014-9609-1. View

2.
Selim M, Foster L, Moy C, Xi G, Hill M, Morgenstern L . Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial. Lancet Neurol. 2019; 18(5):428-438. PMC: 6494117. DOI: 10.1016/S1474-4422(19)30069-9. View

3.
Cao H, Liu T, Chew S . The application of nanofibrous scaffolds in neural tissue engineering. Adv Drug Deliv Rev. 2009; 61(12):1055-64. DOI: 10.1016/j.addr.2009.07.009. View

4.
Ellis-Behnke R, Liang Y, You S, Tay D, Zhang S, So K . Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc Natl Acad Sci U S A. 2006; 103(13):5054-9. PMC: 1405623. DOI: 10.1073/pnas.0600559103. View

5.
Park J, Kim J, Choi S, Kim J, Kim J, Jeon W . Thermo-sensitive assembly of the biomaterial REP reduces hematoma volume following collagenase-induced intracerebral hemorrhage in rats. Nanomedicine. 2017; 13(6):1853-1862. DOI: 10.1016/j.nano.2017.04.001. View